Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - OTHER CURRENT ASSETS
Other Current Assets AKBA - Akebia Therapeutics, Inc.
20.2 M
LAST VALUE
-21.84%
2 YEAR CAGR
-8.43%
5 YEAR CAGR
39.22%
10 YEAR CAGR